Bremelanotide PT 141

Bremelanotide PT 141 binds to and activates a cellular receptor—in this case, the melanocortin receptors associated with pigmentation. Various forms were developed after the peptide was found to be useful in treating sexual disorders.

In its most current form, Bremelanotide PT 141 is administered via a subcutaneous injection. The most suitable sites for injection are where there are fat deposits. Bremelanotide is, therefore, most often injected into the stomach region, lower abdomen, or thigh. The only legitimate form of the peptide is injectable. Pills, nasal sprays, and creams with the name are not legitimate and should not be administered as such.

Effective dosages may vary as everyone responds differently to the substance. A 2-milligram dose is generally effective for men and women, about 1 hour prior to sexual activity. It’s not recommended to exceed this dosage in 72 hours, but experts suggest starting with a 1mg test dose and injecting a similar amount 30 minutes later; testing Bremelanotide in increments to gauge response is considered a safe approach. By consulting a physician or health care provider, you can receive a cycle protocol best suited for your condition.